Literature DB >> 9711297

Essential structural factors of annonaceous acetogenins as potent inhibitors of mitochondrial complex I.

H Miyoshi1, M Ohshima, H Shimada, T Akagi, H Iwamura, J L McLaughlin.   

Abstract

The annonaceous acetogenins are the most potent of the known inhibitors of bovine heart mitochondrial complex I. These inhibitors act, at the terminal electron transfer step of the enzyme, in a similar way to the usual complex I inhibitors, such as piericidin A and rotenone; however, structural similarities are not apparent between the acetogenins and these known complex I inhibitors. A systematic set of isolated natural acetogenins was prepared and examined for their inhibitory actions with bovine heart mitochondrial complex I to identify the essential structural factors of these inhibitors for the exhibition of potent activity. Despite their very potent activity, the structural requirements of the acetogenins are not particularly rigid and remain somewhat ambiguous. The most common structural units, such as adjacent bis-tetrahydrofuran (THF) rings and hydroxyl groups in the 4- and/or 10-positions, were not essential for exhibiting potent activity. The stereochemistry surrounding the THF rings, surprisingly, seemed to be unimportant, which was corroborated by an exhaustive conformational space search analysis, indicating that the model compounds, with different stereochemical arrangements around the THF moieties, were in fairly good superimposition. Proper length and flexibility of the alkyl spacer moiety, which links the THF and the alpha, beta-unsaturated gamma-lactone ring moieties, were essential for the potent activity. This probably results from some sort of specific conformation of the spacer moiety which regulates the two ring moieties to locate into an optimal spatial position on the enzyme. It is, therefore, suggested that the structural specificity of the acetogenins, required for optimum inhibition, differs significantly from that of the common complex I inhibitors in which essential structural units are compactly arranged and conveniently defined. The structure-activity profile for complex I inhibition is discussed in comparison with those for other biological activities.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9711297     DOI: 10.1016/s0005-2728(98)00097-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

Review 1.  Probing the ubiquinone reduction site in bovine mitochondrial complex I using a series of synthetic ubiquinones and inhibitors.

Authors:  H Miyoshi
Journal:  J Bioenerg Biomembr       Date:  2001-06       Impact factor: 2.945

2.  Data mining of NCI's anticancer screening database reveals mitochondrial complex I inhibitors cytotoxic to leukemia cell lines.

Authors:  Constance J Glover; Alfred A Rabow; Yasemin G Isgor; Robert H Shoemaker; David G Covell
Journal:  Biochem Pharmacol       Date:  2006-10-13       Impact factor: 5.858

3.  IACS-010759, a potent inhibitor of glycolysis-deficient hypoxic tumor cells, inhibits mitochondrial respiratory complex I through a unique mechanism.

Authors:  Atsuhito Tsuji; Takumi Akao; Takahiro Masuya; Masatoshi Murai; Hideto Miyoshi
Journal:  J Biol Chem       Date:  2020-04-14       Impact factor: 5.157

4.  Synthesis and anti-tumor activity of carbohydrate analogues of the tetrahydrofuran containing acetogenins.

Authors:  Stewart Bachan; K A Tony; Akira Kawamura; Diego Montenegro; Anjali Joshi; Himanshu Garg; David R Mootoo
Journal:  Bioorg Med Chem       Date:  2013-08-29       Impact factor: 3.641

5.  Synthesis and characterization of new piperazine-type inhibitors for mitochondrial NADH-ubiquinone oxidoreductase (complex I).

Authors:  Naoya Ichimaru; Masatoshi Murai; Nobuyuki Kakutani; Junko Kako; Atsushi Ishihara; Yoshiaki Nakagawa; Takaaki Nishioka; Takao Yagi; Hideto Miyoshi
Journal:  Biochemistry       Date:  2008-09-10       Impact factor: 3.162

6.  Mitochondrial complex I inhibitors, acetogenins, induce HepG2 cell death through the induction of the complete apoptotic mitochondrial pathway.

Authors:  Nuria de Pedro; Bastien Cautain; Angeles Melguizo; Francisca Vicente; Olga Genilloud; Fernando Peláez; Jose R Tormo
Journal:  J Bioenerg Biomembr       Date:  2012-11-21       Impact factor: 2.945

7.  Annonaceous acetogenins nanosuspensions stabilized by PCL-PEG block polymer: significantly improved antitumor efficacy.

Authors:  Jingyi Hong; Yanhong Li; Yijing Li; Yao Xiao; Haixue Kuang; Xiangtao Wang
Journal:  Int J Nanomedicine       Date:  2016-07-18

8.  Bioguided Phytochemical Study of Ipomoea cairica Extracts with Larvicidal Activity against Aedes aegypti.

Authors:  Víctor Álvarez Valverde; Gerardo Rodríguez Rodríguez; Silvia Argüello Vargas
Journal:  Molecules       Date:  2022-02-16       Impact factor: 4.411

9.  Acetogenins from Annona muricata as potential inhibitors of antiapoptotic proteins: a molecular modeling study.

Authors:  Priya Antony; Ranjit Vijayan
Journal:  Drug Des Devel Ther       Date:  2016-04-13       Impact factor: 4.162

Review 10.  Medicinal chemistry of Annonaceous acetogenins: design, synthesis, and biological evaluation of novel analogues.

Authors:  Naoto Kojima; Tetsuaki Tanaka
Journal:  Molecules       Date:  2009-09-17       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.